X-linked IAP protein is a potent inhibitor of cell death. Here, we describe a novel transgenic mouse in which the human XIAP gene is expressed under the control of the neuron-specific enolase promoter (NSE-xiap). We demonstrate that nigrostriatal dopamine neurons of NSE-xiap mice were resistant to the damaging effects of the dopaminergic neurotoxin MPTP. MPTP-induced reduction of striatal dopamine metabolism was also attenuated in NSE-xiap mice. Furthermore, NSE-xiap mice treated with MPTP did not exhibit deficits in exploratory behaviour in an open-field test. Taken together, these findings suggest that strategies to enhance neuronal expression of XIAP may provide therapeutic benefit for the treatment of neurodegeneration in Parkinson's di...
International audienceThe type 2 vesicular monoamine transporter (VMAT2), by regulating the storage ...
International audienceThe type 2 vesicular monoamine transporter (VMAT2), by regulating the storage ...
International audienceThe type 2 vesicular monoamine transporter (VMAT2), by regulating the storage ...
Genetic and biochemical abnormalities of a-synuclein are associated with the pathogenesis of Parkins...
In addition to genetic factors, environmental factors have long been suspected to contribute to the ...
Parkinson's disease (PD) is most commonly a sporadic illness, and is characterized by degeneration o...
The administration of MPTP selectively targets the dopaminergic system resulting in Parkinsonism-lik...
Mutations in the parkin gene are currently thought to be the most common cause of recessive familial...
<p>Transgenic mice expressing moderate levels (∼3-fold over endogenous levels) of wild type (WT, lin...
<div><p>Mutations in the <em>parkin</em> gene are currently thought to be the most common cause of r...
Evidence for involvement of cytochrome P450 2E1 in the MPTP-induced mouse model of PD has been repor...
<p>Samples were collected at 1 day or 3 days from the striatum (A, B) and the substantia nigra (C, D...
Parkinson’s disease (PD) is a neurodegenerative disease characterised by histopathological and bioch...
Parkinson’s disease (PD) is a neurodegenerative disease characterised by histopathological and bioch...
Genetic and biochemical abnormalities of α-synuclein are associated with the pathogenesis of Parkins...
International audienceThe type 2 vesicular monoamine transporter (VMAT2), by regulating the storage ...
International audienceThe type 2 vesicular monoamine transporter (VMAT2), by regulating the storage ...
International audienceThe type 2 vesicular monoamine transporter (VMAT2), by regulating the storage ...
Genetic and biochemical abnormalities of a-synuclein are associated with the pathogenesis of Parkins...
In addition to genetic factors, environmental factors have long been suspected to contribute to the ...
Parkinson's disease (PD) is most commonly a sporadic illness, and is characterized by degeneration o...
The administration of MPTP selectively targets the dopaminergic system resulting in Parkinsonism-lik...
Mutations in the parkin gene are currently thought to be the most common cause of recessive familial...
<p>Transgenic mice expressing moderate levels (∼3-fold over endogenous levels) of wild type (WT, lin...
<div><p>Mutations in the <em>parkin</em> gene are currently thought to be the most common cause of r...
Evidence for involvement of cytochrome P450 2E1 in the MPTP-induced mouse model of PD has been repor...
<p>Samples were collected at 1 day or 3 days from the striatum (A, B) and the substantia nigra (C, D...
Parkinson’s disease (PD) is a neurodegenerative disease characterised by histopathological and bioch...
Parkinson’s disease (PD) is a neurodegenerative disease characterised by histopathological and bioch...
Genetic and biochemical abnormalities of α-synuclein are associated with the pathogenesis of Parkins...
International audienceThe type 2 vesicular monoamine transporter (VMAT2), by regulating the storage ...
International audienceThe type 2 vesicular monoamine transporter (VMAT2), by regulating the storage ...
International audienceThe type 2 vesicular monoamine transporter (VMAT2), by regulating the storage ...